Action of the benzodiazepine antagonist Ro 15-1788 in humans after sleep withdrawal. 1984

H M Emrich, and P Sonderegger, and N Mai

Subsequent to one night of sleep withdrawal the specific benzodiazepine antagonist Ro 15-1788 was infused to 5 healthy volunteers using a double-blind placebo-controlled cross-over design. Using several standardized psychological tests (viso-motor tracking task, complex choice reaction time, trail making test, visual attention and concentration), no performance-improving effects of Ro 15-1788 could be demonstrated. The results are discussed regarding the possible existence of endogenous benzodiazepine ligands.

UI MeSH Term Description Entries
D008297 Male Males
D008606 Mental Processes Conceptual functions or thinking in all its forms. Information Processing, Human,Human Information Processing
D011597 Psychomotor Performance The coordination of a sensory or ideational (cognitive) process and a motor activity. Perceptual Motor Performance,Sensory Motor Performance,Visual Motor Coordination,Coordination, Visual Motor,Coordinations, Visual Motor,Motor Coordination, Visual,Motor Coordinations, Visual,Motor Performance, Perceptual,Motor Performance, Sensory,Motor Performances, Perceptual,Motor Performances, Sensory,Perceptual Motor Performances,Performance, Perceptual Motor,Performance, Psychomotor,Performance, Sensory Motor,Performances, Perceptual Motor,Performances, Psychomotor,Performances, Sensory Motor,Psychomotor Performances,Sensory Motor Performances,Visual Motor Coordinations
D011930 Reaction Time The time from the onset of a stimulus until a response is observed. Response Latency,Response Speed,Response Time,Latency, Response,Reaction Times,Response Latencies,Response Times,Speed, Response,Speeds, Response
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005442 Flumazenil A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses. Flumazepil,Anexate,Lanexat,Ro 15-1788,Romazicon,Ro 15 1788,Ro 151788
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001143 Arousal Cortical vigilance or readiness of tone, presumed to be in response to sensory stimulation via the reticular activating system. Vigilance, Cortical,Arousals,Cortical Vigilance

Related Publications

H M Emrich, and P Sonderegger, and N Mai
August 1984, Der Anaesthesist,
H M Emrich, and P Sonderegger, and N Mai
January 1987, Journal de toxicologie clinique et experimentale,
H M Emrich, and P Sonderegger, and N Mai
August 1985, Lancet (London, England),
H M Emrich, and P Sonderegger, and N Mai
November 1986, British journal of clinical pharmacology,
H M Emrich, and P Sonderegger, and N Mai
June 1986, Archives of internal medicine,
H M Emrich, and P Sonderegger, and N Mai
June 1986, Biological psychiatry,
H M Emrich, and P Sonderegger, and N Mai
September 1982, Science (New York, N.Y.),
H M Emrich, and P Sonderegger, and N Mai
January 1985, European journal of pharmacology,
H M Emrich, and P Sonderegger, and N Mai
May 1983, British journal of clinical pharmacology,
H M Emrich, and P Sonderegger, and N Mai
July 1988, Der Anaesthesist,
Copied contents to your clipboard!